DiscoverAt the EdgeHow a global biopharma is adopting an end-to-end AI transformation
How a global biopharma is adopting an end-to-end AI transformation

How a global biopharma is adopting an end-to-end AI transformation

Update: 2025-07-26
Share

Description

If CEOs want to transform their companies, they must lead with AI and agentic AI—that’s the key to winning a competitive advantage. So says Paul Hudson, CEO of leading pharmaceutical company Sanofi, on this episode of the At the Edge podcast. He speaks with McKinsey Senior Partners Hemant Ahlawat and Lareina Yee about his leadership of a company-wide effort to use AI to expedite drug discovery, gain efficiencies, and remake the company.

See www.mckinsey.com/privacy-policy for privacy information

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How a global biopharma is adopting an end-to-end AI transformation

How a global biopharma is adopting an end-to-end AI transformation

McKinsey Digital